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Since mast cells and basophils are thought to playa 
central role in several types of cutaneous inflalnma-
tory and allergic reactions, and since interleukin-6 
(IL-6) is an important mediator in these processes, we 
have studied the ability of the human mast cell line 
HMC-1, the human basophilic cell line KU812, and 
human skin mast cells to produce IL-6. All three cell 
types proved to be potent sources of this cytokine 
after appropriate stimulation. Transcription of IL-6 
mRNA was first detectable 2 h after stimulation with 
the ester phorbol myristate acetate (PMA) and the 
calcium ionophore A23187 in both cell lines, as evi-
denced by semiquantitative reverse transcriptase 
polymerase chain reaction analysis. Whereas resting 
cells did not produce IL-6 protein, PMAlA23187-
stimulated cells released imn"lllnOreactive and bio-
logically active IL-6, as demonstrated and quanti-
T he role of mast ce lls and basophil s as primal)' effcctor cells in IgE-dependent immediatc hypersensitivity is well cstablished. The finding that activatcd mast cclls arc also a source of several cytokines suggests an ad-ditional ro le of m ast cells in latc-phase reactions and 
other persistent inflammatory processes (for rcview see [1]). 
Among the cytokines known to be produccd by rodent m ast cells. 
interleukin-6 (IL-6), a plciotropic cytokinc with central functions in 
host response to injury and infection , is of parti cular importance. 
IL-6 elicits production of hepatic acute phasc plasma proteins , 
induces differentiation, activation , and/or proliferation ofB cells, T 
cells, and m3crophages, and enhances IL-4-depcndent IgE produc-
tion [2] and the formation of IL-3-dependent l11ultipotcntiaJ colo-
nies in hematopoietic stcm cclls (for review see [3.4]) . IL-6 is 
produced in various phosphoglycosylated forms by monocytes/ 
macrophages, B cells, T cell s, fibrob lasts, endothelial celJs , and 
keratinocytes in rcsponse to cytokines, vil·uses. or endotoxin [3,4]. 
Moreover, ill lIilm production of IL-6 has been demonstrated in 
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Abbrevia tions: RT-PC R . reverse transcriptase polymerase chain reaction; 
r1L-6, recombinant interleukin-6, 
tated by enzyme-linked immunosorbent assay and by 
the use of TEPC 1033 cells, an IL-6-dependent mu-
rine plasmacytoma cell line. Stimulated KU812 cells 
secreted sevenfold more IL-6 (up to 15 ng/ml) than 
HMC-1 cells (up to 2.4 ng/ml). mmunoblotting of 
HMC-1- and KU812 cell-derived IL-6 revealed sev-
eral IL-6 forms in the molecular weight range of21 to 
30 kDa. Imll111nOelectron microscopic studies of hu-
man skin biopsies provided evidence that unstimu-
lated mast cells do not contain preformed IL-6 but 
accumulate IL-6 in cytoplasmic and extruded gran-
ules after IgE-dependent stimulation. These findings 
suggest that IL-6 secreted by human mast cells and 
basophils potentially contributes to allergic, other 
immunologically mediated and nonspecific inflam-
111atory responses. Key IIJol,ds: basopllils. ] l1west Del'"ma-
tol106:75-79, 1996 
activated murine mast cell lines and in prilllary murinc bone 
marrow mast cell cultUl'es [5 ,6] as well as in activated rat peritoneal 
mast cells [7]. 
IL-6 is thought to be involved in several diseases including 
autoiml11une disOl·ders and pl asma cell neoplasias and espccially in 
inflammatory processes of the skin as diverse as sclerodenna [8,9]. 
psoriasis [10] , and delayed pressure urticaria [11] . Also, a contribu-
tion of mast cells and basophils to the pathogenesis of fibrotic 
and/or inflammatory skin diseases such as scleroderma [1 2] , psori-
asis [13] , and bullous pcmphigoid [14 ,15] has been suggested. Tllis 
coincidence of changes in mast cell and basophil numbers and the 
elevations in IL-6 serum levels in several of these diseases led us to 
investigate the ability of human mast cclls and basoplli lic cells to 
produce lL-6 in celJ cultures and in skin biopsies . 
MATERIALS AND METHODS 
Cell Culture HM C-1 . an immature human mast cell line [16] , was main-
tained in Iscove's medium (Seromed, Berlin, German y), supplemented with 
10% FCS (Seromed) and '10 - 5 M monothiog lycerol (Sigma, Dciscnhofen, 
Germany). KU81 2, a human early basophilic leukocyte cell line [J7] . was 
maintained in lU'MI 1640 (Scromcd) / 15°A) fetal bovine serum . I-luman 
fibroblasts were iso lated from foreskin and cultured in Dulbecco's modi.fied 
Eagle's medium/ 1 0% feral bovine serum, All cell culmre media contained 2 
mM glutamine (Seromed) and an tibiotics (Serorned). One million cell s per 
milliliter serum-free medium were stimulated with phorbol m yristate 
acerate (PMA) and / or A23187 (both from Sigma) at va rious concentrations 
and for various time periods , PrcconfIucnt fibroblast cultures were stimu-
lated with 1 ng/ ml IL-1 /3 (specific activity: 5 X 10" units/ mg in the A375 
growth inhibition assay) (Genzyme, Boston. MA) for 24 h in scrum-fi'ce 
Dulbecco's modified Eagle'S medium . 
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EnzYlne-Linked Immunosorbent Assay for IL-6 T he amount of I L-6 
prote in in cell culture supernatants of HMC-l or KUS12 cells was 
determined by a sandwich enzyme-linked immunosorbent assay (ELI SA) 
using a polyclonal goat anti-human IL-6 antibody (British Biotechnology. 
Oxford , U.K.) for coating and a monoclonal mouse anti-human Il-6 
antibody (Hiss Diagnostics. Freiburg. Germany) and a biotinylated goat 
anti-mouse IgG F(ab), fTagment (Medac, Hamburg, Germany) for detec-
tion . Absorption of the streptavidin-alka ljne phosphatase colo r reaction was 
measured at 450 11m al1d compared with serial dilutions of human recom-
binant IL-6 (rIL-6) (specific activity: 1 B9 unjt/ pg) (Hjss Diagnostics) as a 
standard. The lower detection Ijmit was approximately 30 pg/ml. T he 
ELISA did not cross-react with o ther known cytokines such as Il-l a and 
lL-l{3. IL-2, tumor necrosis f.lctor-a or granulocyte-macrophage colony-
stimulating [acto r. 
Bioassay for IL-6 T he IL-6 bioassay was performed by measuring the 
[' I-I] thymidine incorporation rates of the 1l-6-dependent mouse plasma-
cytoma cell line TEPC 1033, as p rev iously described [1 8]. The IL-6 content 
of ce ll cul ture supernatants was quantifIed in comparison to serial dilutions 
of human r1L-6 (Hiss Diagnostics). In o rder to prove specificity, culture 
supernatants we re preincubated w ith a neutra lizing goat anti-human IL-6 
an tibody (1 /-Lg/ml) (Briti sh Biotechnology) or with equal amounts of 
non immune goat [gG (Dianova) in two experiments. 
Polymerase Chain Reaction Analysis Semiq uan titative reverse tran-
scriptase polymerase chain reaction (RT-PCR) analysis was perfo rmed as 
pn!vious ly described [19] . BrieAy, 3 /-Lg of to tal ce ll ul ar I~A. purified by 
the guanidiulll truocyanate/cesiulll chloride method, was transcribed in to 
cDNA using random priming. For comparison of Il-6 mRNA levels in 
difrerent samples. cDNAs were fi rst adj usted to equal concen trations of 
{3-actin by the usc of a {3-actin control fragment [1 9J and were then ana lyzed 
for their content of IL-6 mR.NA . The speci fi city of the ampljfication 
products was verifi ed by restriction analysis with two enzymes indicative of 
the expected amplified sequence (data not shown). To control for con tam-
inations. the polymerase chain reaction (PCR) mixture was amplified 
witho ut cDNA or contai ned RNA tha t had not been reve rse transcribed. 
Prime r sequences for {3-actin (pos ition 1.03-122 and 642-619) and IL-6 
(position 11 3-132 and 311 2-2ll3) were taken fro m Yamamura <I al [20] and 
crossed intron-cxoll boundaries. 
Immnnoprecipita tion and Western Blot Allalysis For immunopre-
. cipi tation, 2 X 10" stimulated and uns ti mulated ce ll s were solubilized in a 
lysis buffer con taining 25 mM Tris-HC[, 1'1-1 7.4. 50 mM N aCl. 0.5% 
sodiumdeoxycho late, 2'Yu NP-40. 0.2% SDS. 1 mM PMSF, and 50 /-Lg/ml 
aproti nin . Cell Iysates were incubated for 2 h with sepharose Cl- 4B (Sigl11a) 
to whkh polyclonal goat anti- human IL-6 (British Biotechno logy) had been 
coupled. To elute sepharose-bound prote in, pellets were boiled for 5 min in 
lX laemml.i buffer 121] . For Western blotting. either eluted protein from 
ce ll Iysates or acetonc precipi tated culture supcrnatants of HM C-l or 
KU8 12 cell s and of fIbroblasts wh.ich had been resuspended in IX L:lemmli 
buffer were electrophoresed through a sodium dodecylsulf;ltc-po lyacrylam-
ide gel e lectrophoresis on 1.2.5% mini-gels (Bio-Rad, R.iclUllOnd, CAl and 
transferred to ni trocellulose filters (Schleicher & Schuell , Dasse[, Germany) 
acco rding to the method of Towbin 122] . Blotted Il-6 was visualized by 
means o f polyclonal goat anti-human IL-6 antibody (British Biotechno-
logy). peroxidase-conjugated rabbi t an ti-goat IgG F(ab)2 fragment (Di-
anova. Hamburg, Germany), and a chemjJum.inescence detection system 
(ECl; Amersham, Braunschweig. German y) . according to the supplier's 
recommendations. Blots were ex posed to Kodak XAR-5 films. Hum,m 
r1l-6 which served as positive contro l was a non-g[ycosyla ted Escllc,.ichia 
coli-deri ved protein of 20.66 and 18.8 illa molecular mass (Hiss Diagnos-
tics). For speci ficity contro l, the anti-human IL-6 al1 tibody was preincu-
bated with excess r1L-6 or was replaced by nonimmune goat IgG (Dianova). 
1111nlllnoelectron Microscopy Fresh slcin specim ens (4-mm punch bi-
opsies from foreslcin) werc preincubatcd with I /-Lg/ ml human IgE (Calbio-
chem . La J o lla . CAl in serum-fi·ce Iscove's mcdium overnight and stimu-
lated w ith 'I /-Lg/ml rabbit anti-human IgE (Behring. Marburg, Germany) for 
16 h . For control , skin biopsies were incuba ted in medium alone or in 
medium contailling either IgE or anti-lgE. After the incuba tions. all 
specimens werc processed fo r immunoelcctron microscopy as previollsly 
described [23]. T isslle sections were incubated with a polyclonal goat 
anti-human Il-6 antibody (Briti sh Biotechnology) and a peroxjdase-conju-
gated rabbit anti-goat IgG F(ab)2 fragment (Dianova). o r with equal 
amollnts of noniml11l1ne goat IgG (Dianova) for specificity control. A mOllse 
anti-human tryptase antibody (AAI) se rved as positive con trol fo r the 
sta ining of mast cell granlli es. 
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Figure 1. Stimnlation of HMC- l cells with PMA and A23187 
indnces IL-6 release . I-IMC-l cell s were treated with PMA (4 2.5 nM) ill 
combination with various concentra tions of A2J"I 87 (0.1 to 0.8 /-LM) for 24 
h. and IL-6 release was measured by ELISA . Untreated ce ll s (C. control) and 
cell s that had been treated with either of the stimuli alo lle (not shown) did 
not secrete [L-6. Erm,. bars, SO of data from three independent e""perimclltS 
(total n = 6). 
RESULTS 
ELISA In ini tia l con cen tration d e p e nd en ce studies, we examined 
the production of IL-6 by HMC-l and KU812 cells after 24-h 
treatment with diffe re nt concentrn io n s of PM A (21.25 nM to 0.34 
J.LM) and/or calcium ionophore A23187 (1 J.LM to 0.01 J.LM). 
HMC-l cells treated with PMA (42.5 nM) in the presen ce of 
various con centrations of A23187 (0.1 to 0.8 J.LM) secreted sub-
stantial amounts of IL-6 in a con centration-de p end ent fashion (Fig 
1) , whereas n e ithe r agent a lone induced sig nificant production of 
IL- 6 in any of the con centrations tested (not sh own) . Max imallL-6 
re lease (up to 2.4 ng/ m l) was obtained by combin e d t re atme nt of 
HMC -l cells with PMA (42.5 nM) and A23187 (0.5 J.LM) (Fig 1). 
KU812 cells, in contrast, produced up to 4.1 n g/ml IL- 6 w hen 
stimu lated with A23187 (0.5 J.LM) alone, and up to 7-fold m ore 
IL-6 (15 n g/ml) compared with HMC-1 cells after costimulation 
w ith PMA (42 .5 nM) (Fig 2). These optimal doses of PMA and 
A23187 were used throughout the subsequent experime nts. In time 
course exp e riments, the re lease of IL-6 b y PMA/ A23187-treated 
HMC-l (Fig 3) and KU812 cells (not shown) starte d within 4 to 
8 h a fter stimulation , p eak e d at 48 to 7 2 h , and d ecline d thereafter. 
Bioassay M axim al pro life ra tive response of TEPC 1033 cells, 
e quiva lent to 400 pg/ ml rIL-6 , was achieved using 1:8 di luted 
supernatantS of HMC- 'I ce lls stimulated with PMA (42.5 nM) and 
A23187 (0.5 J.LM) for 24 h , suggesting a productio n of3200 p g/ml 
IL-6 bioactivity. In contrast, no IL- 6 activity was observed in 
supe rnatants from unstimulated cen s or from cell s exposed to PMA 
(42.5 nM) or A23187 (0.5 J.LM) alone. P re incubation of cell culture 
supe rnatants with a n e utra liz ing anti-rL-6 antibody (1 J.Lg/ml) 
comple tely b locked the prolife rative response of the TEPC 1033 
cells. In con centrations ranging from 10 to 0 .01 J.Lg/ml, the 
antibody completely inhibited ac tivities of up to 500 pg/m l rIL-6 
(not shown). 
RT-PCR Analysis In order to d etermine the time-d e pendent 
express ion of IL- 6 mRNA , HMC-l cells were stimulated with 
PMAI A231 87 for variou s times (as indica ted) , and tota l cellular 
RNA was extracted, reverse ly transcribed into eD NA, and ana-
lyzed by semiquantitative R T -PC R analysis. To provide a m ean-
ingful comparison of the I.L-6 mRNA content of diffe rent samples, 
cDNAs were first normalized to e qua l concentrations of /3-actin 
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Figure 2. Stimulatiou of KU812 cells with PMA and/or A23187 
induces 1L-6 r elease . Cdls were treated wi th PMA (42.S nM) . A2J 187 
(0.5 /-LM), or both for 24 h, and fL ·G secretion was nH!asured b)' ELISA in 
comp,,; son with untreated controls (Collfn>I). E rror bars, SD of three 
independent experiments (tota l n = 6). 
PCR product b y competit ive PCR.. Each cDN A was amplifi ed in 
10-fold (Fig 4a) and subsequently in 2-fo ld dilution steps (Fig 4 b) 
in the prese nce of a fixed amount of /3- acti n con trol fragmen t in 
order to determine the di.lution of eD N A req uired to ac hieve equa l 
band intensities for both /3-actin PCR. products. T he equalized 
cDNAs (Fig 4c) were ana lyzed for IL-6 transcripts using IL-6-
sp ecific prime rs. In accordan ce with th e ELISA da ta , IL-6 mRNA 
was not presen t in unstimulated cells and w as first de tectable 2 h 
a fter stimula tion with PM AI A23187 (Fig 4d) . Stro ng and pro-
lo n ged expression of IL- 6 mRN A was o b served between 4 and 12 
b after stimulation and decl in ed thereafter. 
Immunoblot O n immunoblo t studies, several IL-6 forms could 
be detected in c ul tul'e supe rnatants of PMAI A23187-stim ula ted 
HMC-l and [{V8l2 cells. As illustra ted in Fig 5 , both cell lin es 
secreted four forms of IL-6 of approximate ly 2 1. 23 , 28 , and 30 
kDa. All fo ur IL-6 b ands could be partia lly displaced on th e blot by 
prein cuba tion of the an ti-IL-6 an tibo d y with an excess of rIL-6 
(Fig 5, !all es 8-10). Non e of th ese I L-6 bands was present in th e 
supernatan t of unstimul ated HMC- 1 or KU8l2 cells. In compari -
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Figure 3. PMAlA23187-costimulated HMC-l cells time-depen-
dently release 1L-6. HMC-l cells were treated with the combination of 
PMA (42.5 nM) and A23 .187 (0.5 /-LM) for 0.5 to 86 hand l L·G secretion w:ts 
measured by ELISA. Error bars , SD of three independent experiments (tota l 
n = 6). 
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Figure 4. Expression of 1L- 6 mRNA after costimulatiol1 of HMC-l 
cells with PMA and A23187 increases with time. HM C-l cells treated 
with the cOlllbination ofpMA (42 .5 nM) and A23187 (0.5 /-LM) for O.S to 
2 ~ h were analyzed for their fL·G mRNA contem by semiquantitative 
RT-PC I~. cD NAs of all samples were first ·quali zed for their J3-actin 
concentration by 10- fo ld (n) and 2-fold (b) dil ution steps of the eDNA, in 
the presence of a fixed amount of control fragment to obtain equal band 
intensities of the cD NAs and the control fragme nt (am'"') at each ti me point 
analyzed (35 PC R cycles [cD. The equali zed cDNAs were analyzed for IL-6 
content after 36 pC I~ cycles (d). PCR products were resolved on a 1.5% 
agarose gel and stained by ethidil1m bromide. a) Lall"s 1- 3. cDNA dilutions 
of l :l 0, 1:1 00. 1:1 000 (unstimulated HMC- I ce ll s) b) Lmll's 1-5: cDNA 
di lu tions of 1:12.5, 1 :25, 1 :50, I : I 00, 1 :200 (unstimula ted HM - I cell s) : 
r.d), Lmws 1-8: cDNAs frol11 HMC-l ce ll s stimulated with PMA and 
A23 187 for various tillles (as indicated [hl). To control fo r conramina tions. 
the PCR reaction mixture was amp Li fied with water alone (1\0 . with cDNA 
alone (D) . or with control fragment alone (C); L. I-kb DNA ladder; c.r. . 
control [r:tglllem . 
son , IL- l {3-stimulated tibroblasts produced two fo rms of IL-6 
pro te in of about 23 and 30 kDa (Fig 5, !nlle 3). 
In order to study the expression of in tracellul ar IL- 6 protein, we 
performed i111111unoprecipi tatio n expel;men ts from lysates of both 
ce lJ lines foll owed by i1l1mun o blotting of the eluted prote ins. 
Lysates of PMA I A23 187- stimulated HMC-1 (not sh own) an d 
KU812 cell s contai.ned the sam e fo ur IL-6 isoform s as the respective 
c ul ture supe rnatan ts rang ing fro m 21 to 30 kDa (Fig 6). Lysates of 
unstimula ted cells of both tines , in con trast, did not con tain 
detectable IL-6 protein (Fig 6) . T h e human rlL-6 had a molecular 
weig h t of about 21 and 19 lilia (Fig 5, !nll es I , 7, Fig 6, !nll e 4). 
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Figure 5. Stimulation with PMA and A23187 induces the expres-
sion of 21 , 23, 28, and 30 IcDa IL-6 in HMC-1 and KU812 cells. 
Cul ture supernatants of HM C- I and KU812 cells that had been incuba ted 
for 24 h in the presence (la/les 2,4. respectively) or absence (la/les 5,6. 
respectivel y) of PMA (42.5 nM) and A23187 (0.5 f.l.M) and supernatant of 
lL-l {3 ( I ng/ ml)-stimulated hum an fibrobla sts (la/l e 3) were analyzed by 
immunoblotting, as described in Nlata ;als n/ld I'vleth"ds . All four KU 812 
ce ll-derived I L-6 isoforms could be partially displaced from the blot (lmll' 8) 
by preincubation of the anti- IL-6 an tibody with 350 ng (Ia/l e 9) or 700 ng 
(la/l e 10) of human r1L-6; In/l es 1, 7. human r1L-6. 
Inununoelectron Microscopy In order to furth er examine th e 
biological re lev an ce of o ur findings in cell lines, we studied th e IL-6 
expressio n o f human skin mast cell s by the use o f iml1lunoelectron 
microscopy. Staining for IL-6 was found in mast cells of skin 
bio psies pre in cubated w ith IgE and stimulated with anti-I gE fo r 
16 h . T he electron-dense pe roxidase deposi ts w ere m ainl y o bse rved 
in the intra- (Fig 7a) and extracellular granules (Fig 711) . By 
contrast, mast cell s of unstimlLiated skin (Fig 7 c) and of skin 
stimulated w ith IgE or anti-IgE a lon e (not shown) did not show 
lab e ling . T reatm ent of skin biopsies with PMA and A23187 induced 
also appearance of immunoreactive IL-6 in mast cell g ranules (n ot 
sho wn) . 
DISCUSS IO N 
The present data dem o nstrate the ability of human skin m as t cells to 
produce IL-6 after IgE-dependent stimulation and of a mast cell and 
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Figure 6. Immunoprecipitation of21 , 23, 28, and 30 kDa lL-6 from 
homogenates ofKU812 cells stimulated with PMA and A23187. ell 
Iysa tes were obta ined from KU81 2 ce lls incubated for 4 h in the presence 
(/a/l cs 1,3) or absence (l il lie 2) of PM A (42.5 nM) and A23 187 (0.5 p.M) and 
irnrnunoprecipitated as described in Mll ter;nls alld Me/hods with an anti-IL-6 
antibody (lnll es 1,2) or with non-imlTlune goa t IgG (ln/l e 3). Iml1lun oprc-
cipitates were ana lyzed by SOS-polyacrylamide gel electrophoresis and 
immunoblotting. as described in Mnter;al., 1/111/ Methods. Ln/le 4. human rIL-6. 
The band at about 58 kOa was nonspecific. 
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Figure 7. llUmunoclectron microscopic analysis oflL-6 expression 
in hunlan skin mast cells. Skin samples were prcincuba ted with IgE (I 
f.l.g/ ml) overnight. stimulated with anti- lgE ( I p.g/l1ll ) fo r Iii h. processed 
fo r illlmunoelectron microscopy. and staincd for IL-6, as described ill 
Mntcrillis II l1d Mct liads. In IgE/a nti-lgE-stimulatcd skin samples. there \Va 
strong staining for I L-6 in cytoplasmatic mas t ce ll granules (II). and also iu 
extruded extracd.lular mast cell granulcs (tIIH) II ,l/ cad) (h). Mast cdls of skin 
samples in cubated with medium alone (r). or with IgE or anti-l gE alone (nor 
shown) did not stain for IL-6. Sen /,' h",e<. 0. 1 f.l.11l. 
a basophilic ceU line to pro duce several isofo rms of IL-6 after 
appropriate stimula tion . T h ey confirm previ ou s data on IL-6 pro-
du c ti o n in roden t mast cells and extend th e spectrum of cytokiucs 
reported before for human skin mast cells (IL-4 , IL-8 . tumor 
necrosis fa c tor-a ) [23-25 J. T he abi lity o f no rmal human basophils 
to produce IL-6 has not b een reported b efore . 
Sin ce detail ed studies of IL-6 pro du ction by cutan eo us mast cells 
and by blood basophils a rc hampered b y dill:i culti es assoc iated with 
the purification of these cells and the ir low yie ld afte r su ch pro-
cedures, w e used th e tran sformed , immature HMC- l and KU81 2 
cell lin es instead fo r in vestigation . W e showed that both cell types 
lack expressio n of IL-6 prote in and mRNA in th e unstimulated 
state , in agreement w ith th e immunoelectro n- mic roscopic findings 
in mast cell s of unstimul ated skin. They difFe r, howeve r, frolll 
findin gs in the nasal mucosa w here mast ce ll s were found to sta in 
for IL-6 [26J. T his discrepancy may be explained b y preactivation 
of m ast cell s in nasa l mu cosa due to prior exposure to exogenous 
a ll ergens o r to possible hete roge neity of mast cells regardin g not 
only th e ir protease contents [27J, but also the ir pattern of cytokine 
production [23 ,26J. 
After stimulation with the combination of PMA and A23187 
IL-6 mRNA levels w ere rapidl y upregulate d and main ta ined over 
m any hours in HMC-l cells . This time course of lL-6 mH.N A 
expression is similar to that repo rted for IL-1-stimulated human 
VOL. 106. N O . JANUARY 1996 
synoviocytes [28], but is slow compared with the rapid increase 
(1 h) and decline (4 h) in IgE-stim ulated murine mast cells [29]. The 
kinetics of IL-8 mRNA production by HMC-l ce lls have been 
shown by us to be on the other hand distinctly faster than that of 
IL- 6, using the same stimul i [23]. T his underlines the species-, 
cytokine- , and possibly also stimu lus-dependent differences in the 
kinetics of cytokine synthesis by these cells. 
With respect to secretion of IL-6, the co mbination of PMA and 
A23187 induced maximal IL-6 release in the human mast and the 
basophil ic cell lin e . Moreover, lysates of unstimulated cells of both 
lines did not contaill lll easurablc .lL-6, and stimul ation of the ce lls in 
the presence of cycloheximide completely abolished production of 
IL-6 protein (not shown) , indicati ng de il Oil O generation of TL-6. 
These data suggest that the efficien t induction of IL-6 in both cell 
lines requires delivery of at least two signals , one generated by an 
activation of the protein kinase C and the other by elevation of 
[Ca2 +L as has been suggested for FCERJ-dependent stimula tion of 
cytokine production in mast cells [6,30]. The iml11unoblot data 
show furthermore that both hUl11an mast and basophjlic ce lls 
produce and secrete several IL-6 isoforms after stimu lation. In 
accordance with other types of cells such as monocytes/ macro-
phages, fibroblasts, and endothelial cells where at least three 
O -glycosylated lL- 6 isoforms of23 to 25 kDa and three 0 - and N-
glycosylated species of 27 to 30 kDa could be discriminated 
[31- 33]. 
The rapid synthesis and release of substantial amounts of IL-6 
within a few hours afte r stimulation fr0111 human mast and baso-
phili c cell lines, as reported here , cou ld be of particular importance 
in the induction of inAamIl1atory responses . Its significance in the 
course of diseases i.n which these cell s may playa role [3,4,8-11] 
has yet to be established, although our observations emp hasize the 
potential pathophysiological significance of mast cell- and basophil-
derived cytokines for persistent IgE-dependent as well as nonspe-
cific inflammato ry responses. 
Tllis lIIork III/IS slIp/Jimell b)' (/ ,~mll' '!f ,lie D eli/selic Fo""cilllllgsgelllcillsclinji (Mo 
46212.2). Til " alllllOrs lire gralgid ,,, M rs K. [("s ler alld ivlrs II. Ode/IIPllld for 
e~¥ccl'ellt fer/mica/ nss istnllcC!; to Prc!f T . Din lll nlllste;", D CJ1"rtIll C1l1 (~I l""III1HO/cJ.{! }' , 
Berli ll , for II e1Jdid discussi,,"; III Dr. Blllleljield, Ma)'o C lillic, j ill' pf<lII idillS Ill e 
Hill/C· ·I cells; to 0 " . R iclsell"', Borsld , Gerlllall)' , alld Valelll, Vielllla , A llslrill, )in' 
ril e K U8 J 2 cdls; IIlId 10 Dr. S. IV all, SOlllll allll'((l/1, UK, )in' rll(' AA '/ allliIHlil)'. 
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